Cited by 154Opioid Use Disorder TreatmentPain Management and Opioid UseAnesthesia and Pain Management

The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents

Open access
Häuser, Winfried, Schug, Stephan, Furlan, Andrea D.·2017·PAIN Reports

Abstract

Introduction: A marked rise in opioid prescriptions for patients with chronic noncancer pain (CNCP) with a parallel increase in opioid abuse/misuse, and resulting deaths was noted in the Unites states in the past decade (opioid epidemic). In response, the US Center of Diseases Control (CDC) developed a guideline for prescribing of opioids for patients with CNCP. Objectives: To assess (1) if there is an opioid epidemic in Australia, Canada, and Germany (2) to compare Australian, Canadian, German, and Center of Diseases Control guidelines recommendations for long-term opioid therapy for CNCP. Methods: National evidence-based guidelines and PubMed were searched for recommendations for opioid prescriptions for CNCP. Results: There are signs of an opioid epidemic in Australia and Canada, but not in Germany. Guidelines in all 4 countries provide similar recommendations: opioids are not the first-line therapy for patients with CNCP; regular clinical assessments of benefits and harms are necessary; excessive doses should be avoided (recommended morphine equivalent daily doses range from 50 to 200 mg/d); stopping rules should be followed. All guidelines do not recommend the use of opioids in chronic pain conditions without an established nociceptive or neuropathic cause such as fibromyalgia and primary headache. Conclusion: Implementation of opioid prescribing guidelines should ensure that physicians prescribe opioids only for appropriate indications in limited doses for selected patients and advice patients on their safe use. These measures could contribute to reduce prescription opioid misuse/abuse and deaths.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/pr9.0000000000000599

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [2]Arzneimittelkommission der deutschen Ärzteschaft (Drug Commission of the German Medical Association). UAW-News International Die unkritische Anwendung von Fentanylpflastern erhöht das Risiko für schwerwiegende Nebenwirkungen (The uncritical use of fentanyl patches increases the risk of serious adverse events. Dtsch Ärztebl 2012; 109: A724– 725.
  2. [5]Brennan F Cousins MJ Pain relief as a human right. Pain Clinical Updates 2004; 12: 1– 4.
  3. [42]Müller-Schwefe G Aktionsprogramm Schmerz. Z Angew Schmerzth 1998; 4: 1 Available at: www.schmerz-therapie-deutschland.de/pages/zeitschrift/z4_98/art_401.htm. Accessed December 1, 2016.

Cited by

Sorted by citations

Authors
Häuser, W., Schug, S., & Furlan, A. D.
Affiliations
  • Klinikum Saarbrücken (DE)
  • The University of Western Australia (AU)
  • University of Toronto (CA)
Corresponding author
Häuser, Winfried
Venue
PAIN Reports
Published
2017-05
Volume
2
Issue
3
Pages
e599
ISSN
2471-2531 (ISSN-L)
OpenAlex
W2613863269
Cited by
154
References
54
Citations by year
2026: 6 · 2025: 6 · 2024: 11 · 2023: 4 · 2022: 19 · 2021: 22 · 2020: 26 · 2019: 26 · 2018: 30 · 2017: 4
FWCI
22.08
Type
journal article
Language
en
Open access
Locations
  • PAIN Reports (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Pfizer
  • Seqirus
  • Pfizer Pharmaceuticals
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
Keywords
opioid epidemic, chronic non-cancer pain, opioid prescribing guidelines, opioid misuse, opioid abuse, opioid-related deaths, CDC opioid prescribing guidelines, morphine equivalent daily dose, fibromyalgia, primary headache, Australia, Canada, Germany

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review